NCT05533502

Brief Summary

Nutrient intake of calcium and protein are known to function as regulators of bone remodeling. Specifically, a balanced rate of bone resorption and bone formation (i.e. bone remodeling process) is required to maintain bone health. However, a high remodeling rate, or an imbalance between formation and resorption, as well as suboptimal nutrient intake are known to contribute to fracture risk and bone dysfunction. Gut-derived hormones represent an important link between nutrient intake and bone remodeling (i.e. gut-bone axis). A sustainable nutritional intervention that positively modulates the postprandial responses of gut-derived hormones and the linked bone remodeling processes is an attractive option for the optimization of bone health in young adults. The proposed nutrient intervention seeks to explore the bioefficacy of a combination plant-based protein and marine-based multi-mineral supplement following oral ingestion in young, healthy men and women. A postprandial time-course study will be undertaken to examine the acute effects and/or associations between different gut-derived hormones and biomarkers of bone metabolism.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2022

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

September 5, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 9, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2022

Completed
Last Updated

December 19, 2023

Status Verified

September 1, 2022

Enrollment Period

2 months

First QC Date

September 5, 2022

Last Update Submit

December 18, 2023

Conditions

Keywords

nutritionplantmarineproteinboneskeletalhealthdietary supplementssustainable

Outcome Measures

Primary Outcomes (1)

  • Bone turnover

    A balance of the difference between the magnitude and time course of the acute change (0-4 hours) in plasma C-terminal telopeptide of type 1 collagen (CTX) in ng/mL, a measure of bone resorption, and procollagen type 1 amino-terminal propeptide (P1NP) in ng/ml, a measure of bone formation.

    Pre-ingestion and 15, 30, 45, 60, 90, 120, 180, 240 minutes Post-ingestion (Plasma)

Secondary Outcomes (5)

  • Change in regulator of bone metabolism - Parathyroid hormone

    Pre-ingestion and 15, 30, 45, 60, 90, 120, 180, 240 minutes Post-ingestion (Plasma)

  • Change in ionized calcium and potassium.

    Pre-ingestion and 15, 30, 45, 60, 90, 120, 180, 240 minutes Post-ingestion (Whole Blood)

  • Vitamin D Status

    Pre-ingestion (Plasma)

  • Change in insulin and glucose

    Pre-ingestion and 15, 30, 45, 60, 90, 120, 180, 240 minutes Post-ingestion (Plasma)

  • Change in incretin peptides

    Pre-ingestion and 15, 30, 45, 60, 90, 120, 180, 240 minutes Post-ingestion (Plasma)

Study Arms (2)

Dietary Supplement: Combined Plant-Based Protein and Marine-Based Multi-Mineral Supplement

ACTIVE COMPARATOR

Fava-Bean Protein Concentrate and Aquamin F

Dietary Supplement: Combined Plant-Based Protein and Marine-Based Multi-Mineral Supplement

Placebo Control

PLACEBO COMPARATOR

Placebo Control

Dietary Supplement: Placebo Control

Interventions

Ingestion of the Test Product at 07.00am - Fava-bean protein concentrate dosed at 0.33 g/kg body mass and Aquamin F dosed at 800mg in 500 ml water volume. Supplied by Marigot Limited, Strand Farm Currabinny, Co. Cork, Ireland

Dietary Supplement: Combined Plant-Based Protein and Marine-Based Multi-Mineral Supplement
Placebo ControlDIETARY_SUPPLEMENT

Ingestion of the Control Product at 07.00am - 500ml water volume.

Placebo Control

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Men and women aged 18 to 35 years.
  • Recreationally active (150-300 min/week of moderate physical activity).
  • Healthy (i.e.,not presenting with injury, illness, medication, history of chronic disease, or known allergies/intolerance (e.g. favism) to the ingredients contained in either formulation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Education & Health Sciences, University of Limerick,

Limerick, V94 T9PX, Ireland

Location

Related Links

MeSH Terms

Conditions

Bone Resorption

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal Diseases

Study Officials

  • Philip M Jakeman, PhD

    University of Limerick

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Single Blind Study (Investigator only)
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: A block-randomized, within-subject, two-day, crossover design examining acute (0-4 h) postprandial changes in different gut hormone concentrations and bone remodeling biomarkers in 12 healthy, young adults following ingestion of a combination plant-based protein and marine-based multi-mineral supplement or control.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 5, 2022

First Posted

September 9, 2022

Study Start

September 1, 2022

Primary Completion

October 31, 2022

Study Completion

October 31, 2022

Last Updated

December 19, 2023

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations